Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: A case report

Inflammatory myofibroblastic tumor (IMT) is a rare disease that is considered an intermediate neoplasm, with the risk of recurrence and metastasis. Surgical treatment is the standard therapy for IMT, although there are only a few reports of surgery for lung metastasis of pulmonary IMT. We opine that...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwai, Hidenobu, Yanagawa, Naoki, Deguchi, Hiroyuki, Tomoyasu, Makoto, Shigeeda, Wataru, Kaneko, Yuka, Yoshimura, Ryuichi, Kanno, Hironaga, Sugai, Mayu, Shikanai, Shunsuke, Sugai, Tamotsu, Saito, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260482/
https://www.ncbi.nlm.nih.gov/pubmed/37146628
http://dx.doi.org/10.1111/1759-7714.14914
Descripción
Sumario:Inflammatory myofibroblastic tumor (IMT) is a rare disease that is considered an intermediate neoplasm, with the risk of recurrence and metastasis. Surgical treatment is the standard therapy for IMT, although there are only a few reports of surgery for lung metastasis of pulmonary IMT. We opine that surgical treatment might be effective not only for localized tumors, but also for cases of lung metastasis of IMT.

Ejemplares similares